Published in Women's Health Weekly, March 11th, 2004
The findings, which were announced at the Society of Gynecologic Oncologist's (SGO) Annual Meeting on Women's Cancer, are the first from a randomized controlled clinical trial that tested the effectiveness of the new optical detection technology.
Specifically, the study examined 2,186 women in 13 clinical sites with 51 colposcopists. The researchers found that by using the optical detection system in conjunction with colposcopy, 238...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.